Stay updated on c-MET Positive Clinical Trial

Sign up to get notified when there's something new on the c-MET Positive Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the c-MET Positive Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the overall response rate evaluation with ABBV-399 in patients with c-MET positive SCCA in the Lung-MAP study, a biomarker-driven study for Stage IV or recurrent squamous cell lung cancer.
    Difference
    0.1%
    Check dated 2024-06-06T14:27:35.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participation in the study, specifying health conditions and prior treatments required for patients. Previously, no information was provided about the participation criteria.
    Difference
    39%
    Check dated 2024-05-22T21:15:07.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:40:29.000Z thumbnail image

Stay in the know with updates to c-MET Positive Clinical Trial

Enter your email address, and we'll notify you when there's something new on the c-MET Positive Clinical Trial page.